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Abstract 
AIM: To evaluate the short-term effectiveness of Gamma knife radiosurgery as a modality of treatment of brain 
arteriovenous malformation. 
METHODS: Sixty-three patients with arteriovenous brain malformations underwent Gamma knife radiosurgery 
included in this prospective study between April 2017 and September 2018 with clinical and radiological with MRI 
follow up was done at three months and six months post-Gamma knife radiosurgery. By the end of the 12th-
month post-Gamma knife radiosurgery, the patients were re-evaluated using digital subtraction angiography co-
registered with M.R.I. During the 12 months follow up, CT scan or MRI was done at any time if any one of the 
patients᾽ condition deteriorated or developed signs and symptoms of complications. The mean volume of the 
arteriovenous malformations treated was 26.0 ± 5 cm
3
 (range 12.5–39.5 cm
3
) in The Neurosciences Hospital, 
Baghdad/Iraq. 
RESULTS: By the end of the 12th month of follow up, the overall obliteration of the arteriovenous malformations 
was seen in six patients only (9.5%), while shrinkage was noticed in 57 patients (90.5%). Improvement or clinical 
stability was found in 24 out of 39 patients (61.5%) presented with epilepsy as a chief complaint before Gamma 
knife radiosurgery and 21 out of 24 patients (87.0%) complained of a headache before Gamma knife 
radiosurgery. Post-Gamma knife radiosurgery bleeding was found in only three patients (5.0%). 
CONCLUSION: Even with the short term follow up, Gamma knife radiosurgery has an excellent clinical outcome 
in most patients with arteriovenous brain malformations. The clinical symptoms like headache and seizure were 
either diminished or controlled with the same medical treatment dose before Gamma knife radiosurgery. Long 
term clinical and radiological follow up is recommended. 
 
 
 
Introduction 
 
Brain arteriovenous malformation (AVM), is a 
complex of abnormal arteries and veins that directly 
communicate without an intervening capillary bed, 
with an incidence of 1.12 – 1.42 cases per 100,000 
people each year [1], [2]. Haemorrhage is the most 
common presentation, occurring in 40 – 50% patients 
at initial diagnosis. The annual risk of haemorrhage 
ranges from 1.3 to 4%. The second most common 
presentation is a seizure, occurring in 20 – 30% of 
patients, followed by headache (5%–14%) and focal 
neurological deficits (around 5%) [3], [4]. AVM is the 
second most common cause of intracerebral 
haemorrhage in people < 35 years of age, following 
trauma. Treatment options for cerebral AVM include 
surgery, endovascular treatments, and radiosurgery. 
Among these, stereotactic radiosurgery (SRS) 
showed great benefit in the treatment of small- to 
medium-sized AVMs, by minimising the risk of future 
intracranial haemorrhage with a reduction in 
treatment-related morbidity. The benefit in 
appropriately selected patients who undergo SRS 
reaches approximately 80 – 85% [4]. 
We aimed to evaluate the short-term 
effectiveness of Gamma knife radiosurgery (GKR) is a 
modality of treatment of brain AVM. 
 
 
Patients and Methods 
 
This prospective clinical study which included 
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sixty-three outpatients, referred for radio-surgical 
treatment of an AVM using GKR in The 
Neurosciences Hospital, Baghdad/Iraq for the period 
between April 2017 and September 2018. 
The inclusion criteria were any patient 
diagnosed (clinically and radiologically) to have an 
AVM. All the patients were older than 18, as shown in 
Table 1. All sizes of AVMs included. 
The exclusion criteria were any previous AVM 
intervention, including vascular intervention, 
microsurgery, or previous GKR. 
The average volume of the AVMs was 26.0 
cm
3
 (range, 12.5 – 39.5 cm
3
). The G.K.R. dose was 
16-25 Gy (mean = 20 Gy) — the dose of the radiation 
delivered as a single dose in one session and the 
target was the nidus. The model of the GKR was 
Leksell Gamma Knife, Elekta, Perfexion model. 
All procedures performed without general 
anaesthesia. Instead, intravenous sedative agents 
(i.e., midazolam, thiopental, and/or pentazocine) used 
before frame fixation and local anaesthesia (lidocaine 
2%) applied at the sites of frame fixation. The 
procedure was performed with the patient either fully 
conscious or under sedation, as considered 
appropriate. 
The study protocol approved by our 
institutional review board and conformed to the 
principles of the Declaration of Helsinki. All patients 
provided written informed consent for the use of their 
data. 
 
Follow-up 
Clinical and radiological (MRI) follow up was 
done at three months and six months post-GKR. By 
the end of the 12
th
-month post-GKR, the patients were 
re-evaluated using digital subtraction angiography co-
registered with MRI. During the 12 months follow up, 
CT scan or MRI was done at any time if any one of 
the patients᾽ condition deteriorated or developed signs 
and symptoms of complications. 
The policy of our institution is to re-evaluate 
the patients three years post-GKR using DSA and 
MRI then decide accordingly if the AVM is obliterated 
or further intervention is required. 
 
Statistical analysis 
Descriptive analysis in the form of percentage 
was calculated using Excel and presented in the 
relevant tables shown below. Chi-Square test was 
used for statistical analysis by utilising the Statistical 
Package for Social Sciences (S.P.S.S.) version17 (p-
value < 0.05 was considered significant). 
 
 
Results 
 
The patients᾽ characteristics included in this 
study were summarised in Table 1. 
Table 1: Characteristics of the patients included in the study 
Characteristics  Number of patients (%) 
Male 
Female 
39 (62%) 
24 (38%) 
Total 63 (100%) 
Mean age (years) 47 (range 21-72) 
Mean AVM volume (cm
3
) 26.0 ± 5 (range, 12.50-39.50) 
Presentation: 
Haemorrhage  
Epilepsy  
Headache  
Other (Dizziness, vertigo, focal 
symptoms) 
 
36 (57%) 
39 (61%) 
24 (38%) 
9 (14%) 
Location 
-Hemispheric 
-frontal 
-parietal 
-temporal 
-occipital 
-cerebellar 
-Deep (brain stem, thalamus) 
 
18 (85%) 
3 (14%) 
10 (47%) 
2 (9.5%) 
2 (9.5%) 
1 (5%) 
3 (15%) 
 
The results were concluded using the follow-
up radiological studies (DSA, MRI, and CT Scans) 
and patients' objective presentation of symptoms. 
Table 2: AVM size post-GKR at 12 months follow-up 
AVM size follow up radiologically Total cases 63 % P-value 
Obliteration 6 9.5% P = 0.1 
Shrinkage 57 90.5% P = 0.01 
No change 0 0.0%  
 
 
By the end of the 12
th
 month of follow up, the 
overall obliteration of the A.V.M. was seen in six 
patients only (9.5%, P = 0.1), while shrinkage was 
noticed in 57 patients (90.5%, P = 0.01) (the 
shrinkage ratio was 32.2-78.4%, mean = 68.8%) 
(Table 2, Figures). 
Pre-GKR imaging  
 
One-year follow-up post-GKR  
 
Figure 1: Pre-GKR imaging of left occipital AVM; A) DSA; B) MRI T1 
weighted image with contrast; C) MRI T2 weighted image without 
contrast (top); One-year follow up post-GKR; A) DSA; B) MRI T1 
weighted image with contrast; C) MRI T2 weighted imaging without 
contrast. Showing resolution of left occipital AVM (bottom) 
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Improvement or clinical stability at 12 months, 
without changing the dose of anti-epileptic drugs, was 
found in 24 out of 39 patients presented with epilepsy 
(free of attacks 15.5%, P = 0.01 with decreased 
amplitude time and frequency 46.0%, P = 0.02) as a 
chief complaint before GKR (Table 3).  
Table 3: Seizure attacks post-GKR at 12 months follow-up 
Seizure attacks post-GKR Total of 39 cases % P-value 
Free of attacks 6 15.5% P = 0.01 
Decreased amplitude-time-frequency 18 46.0% P = 0.02 
No change 15 38.5%  
 
Improvement or clinical stability at 12 months, 
without changing the dose of anti-epileptic drugs in 21 
out of 24 patients who complained of headache (free 
of headache 62.5%, P = 0.001 with decreased 
frequency and severity 25.0%, P = 0.01) before GKR 
(Table 4). 
Table 4: Headache attacks post-GKR at 12 months follow-up 
Headache attacks post-GKR Total of 24 cases % P-value 
Free of headache 15 62.5% P = 0.001 
Decreased frequency and severity 6 25.0% P = 0.01 
No change 3 12.5%  
 
Post-GKR bleeding found in only three 
patients (5.0%). These three cases had complained of 
a sudden deterioration in the level of consciousness 
and severe headache after six months of the GKR. 
They were admitted to the hospital and managed 
conservatively (Table 5). 
Table 5: Post-GKR haemorrhage 
Post-GKS haemorrhage Total of 36 cases P-value 
In 3 months 0  
In 6 months 0  
In 12 months 3 P = 0.1 
No haemorrhage 60  
 
The complications encountered during the 12 
months post-GKR follow up were hemianesthesia in 7 
cases (11.1%), hemiparesis in 5 cases (7.9%), 
diplopia in 4 cases (6.3%), hemianopsia in 2 cases 
(3.1%), and ataxia in 1 case (1.5%). CT scan or MRI 
applied for each case. The duration of the symptoms 
was 2-10 days (mean = seven days). All were 
transient and responded well to steroid 
(dexamethasone). 
 
 
Discussion 
 
The most controversial issue on brain AVM 
treatment is the choice of interventional therapy 
modes. G.K.R. treatment could increase the safety of 
interventional surgeries for ruptured or unruptured 
brain AVMs, which are difficult to access by micro-
neurosurgery, high Spetzler Martin (SM) grade, and 
eloquent in location [5]. 
The reported obliteration rate of the nidus in 
the brain AVMs after radiosurgery varies between 43 
and 92%, [5], [6], [7], [8]. In our study, complete 
obliteration was achieved in six of the 63 patients 
(9.5%). This is explained by the short period of follow 
up (12 months). 
Pollock et al., reported that serial MRI was 
predictive of total obliteration in 84% of patients in a 
period of two to four years [9]. Because of its low risk 
and high reliability, it is reasonable to use MRI to 
evaluate obliteration after radiosurgery[10]. 
Kano et al. found that factors associated with 
a higher rate of total obliteration on angiography 
included smaller target volume, smaller maximum 
diameter [8]. 
Friedman et al. reported that complete 
obliteration was obtained in 81% of AVMs between 1 
ml and 4 ml in volume, in 89% of AVMs between 4 ml 
and 10 ml, and 69% of AVMs > 10 ml [11]. Murray et 
al. published increased volume was significantly 
associated with non-obliteration. Volume was a more 
critical factor than eloquent location, patient age, or 
gender [12]. Morphological features of the AVM and 
its density influence the success of AVM obliteration. 
Diffuse AVM structure is associated with a higher risk 
of radiosurgery failure [12], [13]. In our study, the size 
of the lesions was an essential factor as most AVMs 
were large (12.5-39.5 cm
3
 with mean = 26 ± 5 cm
3
). 
The risk of bleeding remains in 1.8-5% of 
patients per year until obliteration can be confirmed 
[9], [11], [14]. The exact mechanisms through which 
radiosurgery reduces the chance of bleeding not 
entirely elucidated. However, the histopathological 
studies of AVM after radiosurgery have suggested 
some theories: A) progressive thickening of the intimal 
layer, which begins as early as three months after 
radiosurgery, appears to decrease the stress to the 
vessel walls, and B) partial or complete thrombosis of 
the irradiated vessels may decrease the number of 
patent vessels in the malformation [5], [15]. 
Der-JenYen et al. reported that concerning 
seizure control, significant seizure reduction found 
following the first 6-months period after GKR. A 28–
66.7% seizure reduction rate compared with that 
before G.K.R. was achieved and no initial worsening 
of seizures in any of the patients after GKS [16]. In our 
study, the post-GKR seizure rate was somehow 
similar to those results, whereas 15.5% were seizure-
free, and about 46.0% were with fewer symptoms. 
Also, no worsening was reported. 
In conclusion, even with the short term follow 
up, GKR has an excellent clinical outcome in most 
patients with brain AVM. The clinical symptoms like 
headache and seizure were either diminished or 
controlled with the same medical treatment dose 
before the GKR. Long term clinical and radiological 
follow up is recommended. 
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